Leukocyte cell-derived chemotaxin 2 (LECT2) is a recently discovered hepatokine that plays crucial roles in various diseases, such as obesity [61], T2D [62], liver fibrosis [63], and hepatocellular carcinoma [64]. Here, LECT2 is linked to obesity disorder.